Clark William D — SEC insider filings
SEC reporting owner CIK 1355415. 15 insider filings on record with FilingPulse; latest filed 2026-10-15.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2020-11-10 to 2026-10-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 6,598 shares, $14,805 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 136,626 shares, $24,959 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 11,435 shares @ $1.10 ($12,579) in GENOCEA BIOSCIENCES, INC., filed 2022-03-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GENOCEA BIOSCIENCES, INC. (GNCA) | President and CEO, Director | 7 | 1 leg · 4,760 sh · $9,806 | 4 legs · 136,626 sh · $24,959 | 9 |
| iBio, Inc. (IBIO) | Director | 6 | 1 leg · 1,838 sh · $4,999 | — | 5 |
| Aldeyra Therapeutics, Inc. (ALDX) | Director | 2 | — | — | 3 |
Insider filings — Clark William D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-15 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 2,323 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-04-18 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 76,760 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | iBio, Inc. (IBIO) | Purchase (P): 1,838 @ $2.72 | EDGAR |
| 2024-11-25 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 18,900 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | GENOCEA BIOSCIENCES, INC. (GNCA) | Sale (S): 4,023 @ $0.06 | EDGAR |
| 2022-06-02 | 4 | GENOCEA BIOSCIENCES, INC. (GNCA) | Sale (S): 117,244 @ $0.06 | EDGAR |
| 2022-04-05 | 4 | GENOCEA BIOSCIENCES, INC. (GNCA) | Sale (S): 3,924 @ $1.25 | EDGAR |
| 2022-03-17 | 4 | GENOCEA BIOSCIENCES, INC. (GNCA) | Grant/award (A): 150,000 @ $0 · Sale (S): 11,435 @ $1.10 · Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2021-12-13 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 109,000 (derivative) @ $0 | EDGAR |
| 2021-08-25 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-03-17 | 4 | GENOCEA BIOSCIENCES, INC. (GNCA) | Grant/award (A): 150,000 @ $0 · Grant/award (A): 450,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | GENOCEA BIOSCIENCES, INC. (GNCA) | Option exercise (M): 16,500 @ $1.66 · Option exercise (M): 19,998 @ $2.72 · Option exercise (M): 19,998 (derivative) @ $0 · Option exercise (M): 16,500 (derivative) @ $0 | EDGAR |
| 2020-11-10 | 4 | GENOCEA BIOSCIENCES, INC. (GNCA) | Purchase (P): 4,760 @ $2.06 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1355415 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs